The University Hand Center at Stony Brook has focused on Dupuytren’s Disease since the opening of University Hospital in 1980. The Hand Center’s success related to the treatment, research and educational efforts surrounding Dupuytren’s Disease has progressed naturally to the formation of the Dupuytren’s Institute at Stony Brook.
It is the mission of the Dupuytren’s Institute to foster: Education, Clinical Training, Continued Medical Education, Research, Community Service and Patient Care.
The Clinical Director of the Institute is:
Lawrence C. Hurst, MD, Chief of Hand Surgery, Professor and Chair - Department of Orthopaedics
The Research Director of the Institute is:
Marie Badalamente, PhD, Professor - Department of Orthopaedics
Drs. Hurst and Badalamente have published extensively on both basic science and the development of a new nonsurgical injection therapy called Injectable collagenase clostridium histolyticum for Dupuytren's contracture. Injectable clostidial collagenase for the treatment of Dupuytren’s Contracture was invented at Stony Brook. See the sidebar for publications, past and present research, and awards.